These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 34839161)
1. Identification of novel influenza polymerase PB2 inhibitors using virtual screening approach and molecular dynamics simulation analysis of active compounds. Xu L; Zhao L; Che J; Zhang Q; Cao R; Li X Bioorg Med Chem; 2021 Dec; 52():116515. PubMed ID: 34839161 [TBL] [Abstract][Full Text] [Related]
2. Virtual Screening and Molecular Dynamics Simulation Study of Influenza Polymerase PB2 Inhibitors. Zong K; Xu L; Hou Y; Zhang Q; Che J; Zhao L; Li X Molecules; 2021 Nov; 26(22):. PubMed ID: 34834044 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir. Patel MC; Chesnokov A; Jones J; Mishin VP; De La Cruz JA; Nguyen HT; Zanders N; Wentworth DE; Davis TC; Gubareva LV Antiviral Res; 2021 Apr; 188():105035. PubMed ID: 33581212 [TBL] [Abstract][Full Text] [Related]
4. Novel influenza polymerase PB2 inhibitors for the treatment of influenza A infection. Zhang H; Zhou L; Amichai S; Zandi K; Cox B; Schinazi R; Amblard F Bioorg Med Chem Lett; 2019 Oct; 29(20):126639. PubMed ID: 31493987 [TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Influenza Polymerase PB2 Inhibitors Using a Cascade Docking Virtual Screening Approach. Zhao L; Che J; Zhang Q; Li Y; Guo X; Chen L; Li H; Cao R; Li X Molecules; 2020 Nov; 25(22):. PubMed ID: 33202790 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1. Lin MI; Su BH; Lee CH; Wang ST; Wu WC; Dangate P; Wang SY; Huang WI; Cheng TJ; Lin OA; Cheng YS; Tseng YJ; Sun CM Eur J Med Chem; 2015 Sep; 102():477-86. PubMed ID: 26310893 [TBL] [Abstract][Full Text] [Related]
7. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor". Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858 [TBL] [Abstract][Full Text] [Related]
8. Methyl brevifolincarboxylate, a novel influenza virus PB2 inhibitor from Canarium Album (Lour.) Raeusch. Chen F; Yang L; Zhai L; Huang Y; Chen F; Duan W; Yang J Chem Biol Drug Des; 2020 Nov; 96(5):1280-1291. PubMed ID: 32519462 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, Biological Evaluation, and Molecular Dynamics Simulation of Influenza Polymerase PB2 Inhibitors. Li X; Xu Y; Li W; Che J; Zhao X; Cao R; Li X; Li S Molecules; 2023 Feb; 28(4):. PubMed ID: 36838837 [TBL] [Abstract][Full Text] [Related]
10. Structural and Thermodynamic Analysis of the Resistance Development to Pimodivir (VX-787), the Clinical Inhibitor of Cap Binding to PB2 Subunit of Influenza A Polymerase. Gregor J; Radilová K; Brynda J; Fanfrlík J; Konvalinka J; Kožíšek M Molecules; 2021 Feb; 26(4):. PubMed ID: 33673017 [TBL] [Abstract][Full Text] [Related]
11. Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening. Liu M; Lo CY; Wang G; Chow HF; Ngo JC; Wan DC; Poon LL; Shaw PC Antiviral Res; 2017 Aug; 144():186-195. PubMed ID: 28629986 [TBL] [Abstract][Full Text] [Related]
12. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface. Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201 [TBL] [Abstract][Full Text] [Related]
15. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation. Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region. McGowan DC; Balemans W; Embrechts W; Motte M; Keown JR; Buyck C; Corbera J; Funes M; Moreno L; Cooymans L; Tahri A; Eymard J; Stoops B; Strijbos R; Van den Berg J; Fodor E; Grimes JM; Koul A; Jonckers THM; Raboisson P; Guillemont J J Med Chem; 2019 Nov; 62(21):9680-9690. PubMed ID: 31647875 [TBL] [Abstract][Full Text] [Related]
17. Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions. Xu L; Jiang W; Jia H; Zheng L; Xing J; Liu A; Du G Front Cell Infect Microbiol; 2020; 10():16. PubMed ID: 32117796 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors. Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229 [TBL] [Abstract][Full Text] [Related]
19. Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling. Tran L; Choi SB; Al-Najjar BO; Yusuf M; Wahab HA; Le L Molecules; 2011 Dec; 16(12):10227-55. PubMed ID: 22158591 [TBL] [Abstract][Full Text] [Related]
20. Fragment-Based Identification of Influenza Endonuclease Inhibitors. Credille CV; Chen Y; Cohen SM J Med Chem; 2016 Jul; 59(13):6444-54. PubMed ID: 27291165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]